Abstract:Objective: To investigate the effects of 15-deoxy-prostaglandin J2 (15d-PGJ2), a peroxisome proliferatoractivated receptor γ (PPARγ) endogenous ligand, on proliferation and apoptosis of human HepG2 cells and to explore the potential mechanism. Methods: 15d-PGJ2 at different concentrations was used to treat the HepG2 cells cultured in vitro, MTT colorimetry was employed to measure proliferation of the cells, and 3H-TdR uptake test was used to measure the synthetic rate of the cells. The expressions of PPARγ mRNA and protein were measured by reverse transcription-polymerase chain reaction (RT-PCR) and western blot. Cell apoptosis rate and cell cycle were analyzed by flow cytometry (FCM). And the effects of PPARγ-specific antagonist (GW9662) and/or transient transfection pSG5-PPARγ eukaryotic expression plasmid on proliferation of the HepG2 cells were also observed, and pGCsi-PPARγ was used to transfect the cells to observe the effects of 15d-PGJ2 on proliferation of the HepG2 cells in the silence of PPARγ. The DNA binding activity of NF-κB was detected by electrophoretic mobility shift assay (EMSA). Results: 15d-PGJ2 at different concentrations inhibited cell proliferation, DNA synthetic rate and induced apoptosis in a dose-dependent manner in HepG2 cells; in this process, the proportion of G0/G1 phase cells increased significantly while the proportion of S phase cells decreased significantly, and the expression levels of PPARγ mRNA and protein were not changed. GW9662 antagonized the proliferation inhibition effect of 15d-PGJ2, but didn’t block completely. However, transfection with a PPARγ-pSG5 expression plasmid restored the effect of 15d-PGJ2 on cell growth in presence of GW9662. After transfection with pGCsi-PPARγ, 15d-PGJ2 also inhibited cell proliferation at 20 μmol·L-1. Furthermore, 15d-PGJ2 inhibited the DNA binding activity of NF-κB at a higher concentration (50 μmol·L -1). Conclusion: 15d-PGJ2 inhibits cell growth, induces apoptosis and interferes with cell cycle of the HepG2 cells, which indicates that the activation of PPARγ is anti-neoplastic in HCC. This effect involves the PPARγ-dependent and PPARγ-independent pathways, which is related to the inhibition of NF-κB signaling pathway.

Inhibition of gastric cancer cells associated angiogenesis by 15d-prostaglandin J2 through the downregulation of angiopoietin-1.

15D-Pgj2 Inhibits Cell Growth and Induces Apoptosis of MCG-803 Human Gastric Cancer Cell Line.

Inhibition Of Gastric Cancer-Associated Angiogenesis By Antisense Cox-2 Transfectants

[Effect of Human Angiopoietin-1 on Tumorigenesis and Angiogenesis of Gastric Cancer].

PGE(2) up-regulates vascular endothelial growth factor expression in MKN28 gastric cancer cells via epidermal growth factor receptor signaling system

Angiostatin Up-Regulation in Gastric Cancer Cell SGC7901 Inhibits Tumorigenesis in Nude Mice

ANGPTL1 Attenuates Colorectal Cancer Metastasis by Up-Regulating Microrna-138

Effects and mechanism of 15-deoxy-prostaglandin J 2 on proliferation and apoptosis of human HepG 2 cells

Effects of 15-Deoxy-delta(12,14)-prostaglandin J(2) on Cell Proliferation and Apoptosis in Ecv304 Endothelial Cells

Effects of prostaglandin E2 on expression of vascular endothelial growth factor in human gastric cancer cell line MKN28

Prostaglandin 15d-PGJ2 inhibits proliferation of lung adenocarcinoma cells by inducing ROS production and activation of apoptosis via sirtuin-1

Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways

POFUT1 inhibits angiogenesis of human gastric adenocarcinoma xenografts in nude mice

Inhibitive Effects of 15-Deoxy-delta(12,14)-prostaglandin J(2) on Hepatoma-Cell Proliferation Through Reactive Oxygen Species-Mediated Apoptosis

ω-3 and ω-6 Polyunsaturated Fatty Acids Regulate the Proliferation, Invasion and Angiogenesis of Gastric Cancer Through COX/PGE Signaling Pathway

Pigment Epithelium-Derived Factor Inhibits Angiogenesis and Growth of Gastric Carcinoma by Down-Regulation of VEGF.

Inhibitive effects of 15-deoxy-Δ(12),(14)-prostaglandin J2 on hepatoma-cell proliferation through reactive oxygen species-mediated apoptosis

Effect of Prostaglandin Reductase 1 (PTGR1) on Gastric Carcinoma Using Lentivirus-Mediated System.

The function and mechanism of COX-2 in angiogenesis of gastric cancer cells

15-Deoxy-Δ12,14-prostaglandin J2 induces expression of 15-hydroxyprostaglandin dehydrogenase through Elk-1 activation in human breast cancer MDA-MB-231 cells

15-Hydroxyprostaglandin dehydrogenase is a tumor suppressor of human gastric cancer.